Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries. (Q51795640)
Jump to navigation
Jump to search
scientific article published on 8 December 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries. |
scientific article published on 8 December 2009 |
Statements
1 reference
Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries. (English)
1 reference
A B Hardy
1 reference
R Varma
1 reference
T Collyns
1 reference
S J Moffitt
1 reference
C Mullarkey
1 reference
J P Watson
1 reference
8 December 2009
1 reference
1 reference
65
1 reference
2
1 reference
178-180
1 reference
Identifiers
1 reference